Golden has been acquired by ComplyAdvantage.Read about it here ⟶

List of Neumedicines Inc. patents

List of Neumedicines Inc. patents

List of Apollo Endosurgery patents

List of Astrapi Corporation patents

List of Topsy Labs patents

List of companies in Saltagen Ventures's investment portfolio

List of awards received by The Twilight Saga: Eclipse

Patents where

Current Assignee

Name

is

Neumedicines Inc.

	Name	Description	Patent Applicant	Current Assignee	Inventor	Patent Jurisdiction	Patent Number	Date of Patent
	‌ US Patent 9636381 Methods for radiation protection by administering IL-12	Patent 9636381 was granted and assigned to Neumedicines Inc. on May, 2017 by the United States Patent and Trademark Office.	Neumedicines Inc.	Neumedicines Inc.		United States Patent and Trademark Office	9636381	May 2, 2017
	‌ US Patent 9616106 IL-12 for radiation protection and radiation-induced toxicity mitigation	Patent 9616106 was granted and assigned to Neumedicines Inc. on April, 2017 by the United States Patent and Trademark Office.	Neumedicines Inc.	Neumedicines Inc.		United States Patent and Trademark Office	9616106	April 11, 2017
	‌ US Patent 8735342 Method for treating brain cancer using a novel tumor suppressor gene and secreted factor	Patent 8735342 was granted and assigned to Neumedicines Inc. on May, 2014 by the United States Patent and Trademark Office.		Neumedicines Inc.		United States Patent and Trademark Office	8735342	May 27, 2014
	‌ US Patent 9925246 Mitigation of cutaneous injury with IL-12	Patent 9925246 was granted and assigned to Neumedicines Inc. on March, 2018 by the United States Patent and Trademark Office.		Neumedicines Inc.		United States Patent and Trademark Office	9925246	March 27, 2018
	‌ US Patent 9463219 Method for treating brain cancer using a novel tumor suppressor gene and secreted factor	Patent 9463219 was granted and assigned to Neumedicines Inc. on October, 2016 by the United States Patent and Trademark Office.	Neumedicines Inc.	Neumedicines Inc.		United States Patent and Trademark Office	9463219	October 11, 2016
	‌ US Patent 8962317 Uses of IL-12 and the IL-12 receptor positive cell in tissue repair and regeneration	Patent 8962317 was granted and assigned to Neumedicines Inc. on February, 2015 by the United States Patent and Trademark Office.		Neumedicines Inc.		United States Patent and Trademark Office	8962317	February 24, 2015
	‌ US Patent 9878012 IL-12 formulations for enhancing hematopoiesis	Patent 9878012 was granted and assigned to Neumedicines Inc. on January, 2018 by the United States Patent and Trademark Office.		Neumedicines Inc.		United States Patent and Trademark Office	9878012	January 30, 2018
	‌ US Patent 8921315 Method of increasing survival of a human subject having exposure to an acute exposure to non-therapeutic whole body ionization by administering a therapeutically effective dose of IL-12	Patent 8921315 was granted and assigned to Neumedicines Inc. on December, 2014 by the United States Patent and Trademark Office.		Neumedicines Inc.		United States Patent and Trademark Office	8921315	December 30, 2014
	‌ US Patent 8846392 Uses of IL-12 and the IL-12 receptor positive cell in tissue repair and regeneration			Neumedicines Inc.		United States Patent and Trademark Office	8846392	September 30, 2014

9 results

0 selected

9 results

0 selected